Teva Launches Generic Proscar
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva has 180-day exclusivity for its generic version of Merck's Proscar (finasteride), the generics firm announced June 19
You may also be interested in...
If You Can't Beat Em'…Merck Signs Authorized Generic Deal For Zocor And Proscar
Dr. Reddy's will sell authorized generics of Zocor and Proscar upon expiration of their respective patents in June.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.